| If this is not your name, click here. | | |
| | Contact Us | Order Now | Journals | Bookstore | Register a colleague | | |
| | | ![]() Options for Managing Behaviour Complications of Dementia: Presented at AAGP By Carole VanSickle Ellis SAVANNAH, Ga -- March 9, 2010 -- Healthcare professionals and caregivers of patients with Alzheimer’s disease and dementia living in nursing facilities may benefit from strategies for dealing with dementia and related behaviour complications that have little to do with medication. Amita Patel, MD, Wright State University, Dayton, Ohio, and Yadagiri Chepuru, Healthcare System, Yonkers, New York, revealed the results of several years’ worth of analysis and carefully implemented changes in nursing facilities in the New York area here on March 8 at the 2010 Annual Meeting of the American Association for Geriatric Psychiatry (AAGP). Even though Alzheimer’s and dementia patients are not necessarily rooted in reality, their symptoms do have an origin, stated the research team. This origin is often environmental, and may stem from a lack of communication, chronically unfamiliar circumstances, intrusive care, loss of control, and chronic pain and discomfort. These issues are often compounded by classic dementia behaviour complications like disinhibition, paranoia, hallucinations, delusions, and aggressive behaviour. Consequences of these behaviour complications often include falls, injuries to the patient, bystanders and caregivers, practitioner malpractice burden, legal issues, and significant caregiver burden. Understanding the source of the behaviour issues -- even if that source is not entirely logical or even rooted in reality -- can enable a caregiver and a physician to develop long-term, effective, and personalised solutions to behaviour problems that result in a better quality of life for everyone involved. The team identified triggers for behavioural complications of dementia. These include: The researchers believe that by identifying potential triggers for patients, caregivers, and staff can be better prepared to deal with episodes. Funding for this research was provided by Forest Laboratories, Pfizer, AstraZeneca, Wyeth, Eli Lilly, and sanofi-aventis. [Presentation title: Treatment of Behavior Complications of Dementia: A Comprehensive, Multi-Disciplinary Care Approach. Abstract S39]
|